U.S. stock-index futures traded mixed on Wednesday, as investors weighed Nike’s (NKE) solid quarterly results and Johnson & Johnson’s (JNJ) announcement of a late-stage trial for its COVID-19 vaccine candidate against concerns that economic activity might slow further in the wake of a coronavirus resurgence.
Global Stocks:
Index/commodity | Last | Today's Change, points | Today's Change, % |
Nikkei | 23,346.49 | -13.81 | -0.06% |
Hang Seng | 23,742.51 | +25.66 | +0.11% |
Shanghai | 3,279.71 | +5.41 | +0.17% |
S&P/ASX | 5,923.90 | +139.80 | +2.42% |
FTSE | 5,950.66 | +121.20 | +2.08% |
CAC | 4,840.76 | +67.92 | +1.42% |
DAX | 12,750.77 | +156.38 | +1.24% |
Crude oil | $39.99 | +0.48% | |
Gold | $1,882.40 | -1.32% |